Skip to content

Prevalence of Foot Pathologies in Persistent High Heel Wearers versus Non High Heel Wearers

Prevalence of Foot Pathologies in Persistent High Heel Wearers versus Non High Heel Wearers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614000897662
Enrollment
20
Registered
2014-08-22
Start date
2014-08-21
Completion date
2014-10-19
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This research aims to identify the prevalence of foot pathologies in a female population of persistent high heel footwear users compared to those who do not regularly wear high heel footwear. We seek to identify if there is a correlation between the persistency of high heel footwear use (how many years, how many hours per day) against the severity and number of foot pathologies versus those who use non high heel footwear. We hypothesize that the prevalence of foot pathologies (such as hallux valgus, metatarsalgia, hyperkeratosis, neuroma, digital deformity) in a female population who are habitual high-heel wearers will be significantly higher compared to non-high heel wearers.

Interventions

Participants will be required to complete an online survey about their current and past shoe wear use and will then be clinically examined to investigate for the presence of foot pathologies.

Sponsors

Laurence Foley
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1 Aged 18-45 years old 2 Female 3 Not pregnant 4 Competent in English 5 Subjects who wear any form of footwear for the majority of their week for more than 10 hours a week.

Exclusion criteria

Previous lower limb surgery (in the last 6 months) Chronic disease such as diabetes, inflammatory diseases and autoimmune diseases Professional athletes Pregnant women

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026